Capital Investment Advisors LLC raised its AbbVie Inc. stake by 2.3% to 313,064 shares valued at $71.53 million. Other institutional investors also bought in, while some executives sold substantial shares recently.

NodeGuardian

2026-04-18 23:47:37

Abstract generation in progress

Capital Investment Advisors LLC increased its stake in AbbVie Inc. (NYSE:ABBV) by 2.3% in the fourth quarter, bringing its total holdings to 313,064 shares valued at $71.53 million, making it the 24th largest holding. Other institutional investors like Evolution Wealth Management Inc. and Chelsea Counsel Co. also acquired new positions in AbbVie. Meanwhile, several AbbVie executives, including EVP Perry C. Siatis and SVP David Ryan Purdue, sold significant portions of their shares during February and March.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

Reward
like
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
GatePreIPOsLaunchesWithSpaceX
258.77K Popularity
#
Gate13thAnniversaryLive
838.8K Popularity
#
CryptoMarketsDipSlightly
192.37K Popularity
#
USIranTensionsShakeMarkets
498.66K Popularity
#
KelpDAOBridgeHacked
15.04K Popularity

Sitemap

AbbVie Inc. $ABBV Shares Bought by Capital Investment Advisors LLC

Trending Topics

GatePreIPOsLaunchesWithSpaceX

Gate13thAnniversaryLive

CryptoMarketsDipSlightly

USIranTensionsShakeMarkets

KelpDAOBridgeHacked

Pin